1. Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes

   • Sanjay Kalra
   • Anu Gupta

   Editorial Open access 09 February 2018 Pages: 441 - 447

2. EADSG Guidelines: Insulin Therapy in Diabetes

   • Bahendeka Silver
   • Kaushik Ramaiya
   • Anthony Makhoba

   Guidelines Open access 05 March 2018 Pages: 449 - 492

   

3. Diabetes in the Elderly

   • Sanjay Kalra
   • Suresh K. Sharma

   Practical Approach Open access 19 February 2018 Pages: 493 - 500

4. Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes

   • Lori Berard
   • Noreen Antonishyn
   • Jean-François Yale

   Practical Approach Open access 23 February 2018 Pages: 501 - 519

   

5. Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment

   • Maria J. Peláez-Jaramillo
   • Allison A. Cárdenas-Mojica
   • Carlos O. Mendivil

   Review Open access 06 February 2018 Pages: 521 - 543

   

6. Herpes Zoster and Diabetes Mellitus: A Review

   • Marianthi Papagianni
   • Symeon Metallidis
   • Konstantinos Tziomalos

   Review Open access 08 March 2018 Pages: 545 - 550

7. Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes

   • Steven P. Marso
   • Elise Hardy
   • Robert J. Chilton

   Original Research Open access 03 February 2018 Pages: 551 - 564

   

8. Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States

   • Cheryl Neslusan
   • Anna Teschemaker
   • Lien Vo

   Original Research Open access 06 February 2018 Pages: 565 - 581

   

9. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study

   • Sarah J. Hallberg
   • Amy L. McKenzie
   • Jeff S. Volek

   Original Research Open access 07 February 2018 Pages: 583 - 612

   

10. Author Correction: Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study

    • Sarah J. Hallberg
    • Amy L. McKenzie
    • Jeff S. Volek

    Author Correction Open access 05 March 2018 Pages: 613 - 621

11. Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies

    • Takashi Kadowaki
    • Kazuyo Sasaki
    • Yoshiteru Ushirogawa

    Original Research Open access 12 February 2018 Pages: 623 - 636

    

12. Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population

    • Kristina S. Boye
    • Fady T. Botros
    • Maureen J. Lage

    Original Research Open access 19 February 2018 Pages: 637 - 650

    

13. Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study

    • Jelica Bjekić-Macut
    • Teodora Beljić Živković
    • Radivoj Kocić

    Original Research Open access 19 February 2018 Pages: 651 - 662

    

14. Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study

    • Jelica Bjekić-Macut
    • Teodora Beljić Živković
    • Radivoj Kocić

    Author Correction Open access 22 March 2018 Pages: 663 - 663

15. Analysis of Postprandial Glycemia in Relation to Metabolic Compensation and Other Observed Parameters of Outpatients with Type 2 Diabetes Mellitus in the Czech Republic

    • Denisa Janíčková Žďárská
    • Martin Hill
    • Jan Brož

    Original Research Open access 19 February 2018 Pages: 665 - 672

16. A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis

    • Yue Gao
    • Ke Wang
    • Bao Liu

    Original Research Open access 23 February 2018 Pages: 673 - 682

    

17. User Performance Evaluation of Four Blood Glucose Monitoring Systems Applying ISO 15197:2013 Accuracy Criteria and Calculation of Insulin Dosing Errors

    • Guido Freckmann
    • Nina Jendrike
    • Cornelia Haug

    Original Research Open access 03 March 2018 Pages: 683 - 697

    

18. Effects of Insulin Lispro Mix 25 and Insulin Lispro Mix 50 on Postprandial Glucose Excursion in Patients with Type 2 Diabetes: A Prospective, Open-Label, Randomized Clinical Trial

    • Wei Li
    • Fan Ping
    • Yuxiu Li

    Original Research Open access 08 March 2018 Pages: 699 - 711

    

19. Adherence to Insulin, Emotional Distress, and Trust in Physician Among Patients with Diabetes: A Cross-Sectional Study

    • Lucine Halepian
    • Mary Bou Saleh
    • Lydia Rabbaa Khabbaz

    Original Research Open access 08 March 2018 Pages: 713 - 726

20. Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries

    • Martin Haluzik
    • Adam Kretowski
    • Nebojsa Lalic

    Original Research Open access 09 March 2018 Pages: 727 - 741

    

21. Factors That Influence Pancreatic Beta Cell Function and Insulin Resistance in Newly Diagnosed Type 2 Diabetes Patients: A Sub-Analysis of the MARCH Trial

    • Yan Duan
    • Jia Liu
    • Guang Wang

    Original Research Open access 09 March 2018 Pages: 743 - 752

22. Adverse Drug Events Associated with Low-Dose (10 mg) Versus High-Dose (25 mg) Empagliflozin in Patients Treated for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    • Xia Dai
    • Zu-chun Luo
    • Feng Huang

    Original Research Open access 09 March 2018 Pages: 753 - 770

    

23. Insulin Glargine Combined with Oral Antidiabetic Drugs for Asians with Type 2 Diabetes Mellitus: A Pooled Analysis to Identify Predictors of Dose and Treatment Response

    • Tianwei Gu
    • Ting Hong
    • Dalong Zhu

    Original Research Open access 09 March 2018 Pages: 771 - 787

    

24. Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study

    • Marco Orsini Federici
    • Janette McQuillan
    • Kirsi Norrbacka

    Original Research Open access 10 March 2018 Pages: 789 - 801

    

25. Changing Patients’ Treatment Preferences and Values with a Decision Aid for Type 2 Diabetes Mellitus: Results from the Treatment Arm of a Randomized Controlled Trial

    • Robert A. Bailey
    • Alicia C. Shillington
    • Nananda Col

    Original Research Open access 13 March 2018 Pages: 803 - 814

    

26. Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study

    • Xin Qian
    • Hui Wang
    • Guangwei Li

    Original Research Open access 13 March 2018 Pages: 815 - 826

    

27. Similar Efficacy and Safety of Basaglar^® and Lantus^® in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study

    • Robyn K. Pollom
    • Timothy Costigan
    • Priscilla A. Hollander

    Original Research Open access 14 March 2018 Pages: 827 - 837

    

28. Clinical and Cost Implications of Insulin Degludec in Patients with Type 1 Diabetes and Problematic Hypoglycemia: A Quality Improvement Project

    • Muhammad Ali Karamat
    • Shujah Dar
    • Abd A. Tahrani

    Original Research Open access 16 March 2018 Pages: 839 - 849

    

29. Pharmacovigilance Evaluation of the Association Between DPP-4 Inhibitors and Heart Failure: Stimulated Reporting and Moderation by Drug Interactions

    • Gian Paolo Fadini
    • Mayur Sarangdhar
    • Angelo Avogaro

    Original Research Open access 16 March 2018 Pages: 851 - 861

    

30. Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes

    • Atsutaka Yasui
    • Ganghyuck Lee
    • Tomoo Okamura

    Brief Report Open access 27 February 2018 Pages: 863 - 871